BRIEF-Janssen To Acquire Benevir Biopharm To Advance Immunotherapy Regimens – Reuters
|
BRIEF-Janssen To Acquire Benevir Biopharm To Advance Immunotherapy Regimens
Reuters May 2 (Reuters) – Johnson & Johnson: * JANSSEN TO ACQUIRE BENEVIR BIOPHARM TO ADVANCE IMMUNOTHERAPY REGIMENS. * JANSSEN BIOTECH- ENTERED INTO A DEFINITIVE AGREEMENT UNDER WHICH IT WILL ACQUIRE BENEVIR BIOPHARM. * JANSSEN BIOTECH – BENEVIR WILL MAINTAIN … |
